Clobetasol + Clotrimazole + Fusidic Acid is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Clobetasol + Clotrimazole + Fusidic Acid is used -
Moderate
Mild
Is the use of Clobetasol + Clotrimazole + Fusidic Acid safe for pregnant women?
Clobetasol + Clotrimazole + Fusidic Acid is safe for pregnant women.
Is the use of Clobetasol + Clotrimazole + Fusidic Acid safe during breastfeeding?
Clobetasol + Clotrimazole + Fusidic Acid is safe for breastfeeding women.
What is the effect of Clobetasol + Clotrimazole + Fusidic Acid on the Kidneys?
Clobetasol + Clotrimazole + Fusidic Acid is not harmful for kidneys.
What is the effect of Clobetasol + Clotrimazole + Fusidic Acid on the Liver?
Using Clobetasol + Clotrimazole + Fusidic Acid does not have any harmful effects on the liver.
What is the effect of Clobetasol + Clotrimazole + Fusidic Acid on the Heart?
There are no any side effects of Clobetasol + Clotrimazole + Fusidic Acid for the heart.
Clobetasol + Clotrimazole + Fusidic Acid should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Clobetasol + Clotrimazole + Fusidic Acid unless your doctor advises you to do so -
Is this Clobetasol + Clotrimazole + Fusidic Acid habit forming or addictive?
Forming a habit of Clobetasol + Clotrimazole + Fusidic Acid has not been reported.
Interaction between Food and Clobetasol + Clotrimazole + Fusidic Acid
It is safe to take Clobetasol + Clotrimazole + Fusidic Acid with food.
Interaction between Alcohol and Clobetasol + Clotrimazole + Fusidic Acid
It is difficult to say anything about the effect of Clobetasol + Clotrimazole + Fusidic Acid and alcohol. No research has been done on this yet.
No, Clobetasol + Clotrimazole + Fusidic Acid should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Yes, Clobetasol + Clotrimazole + Fusidic Acid might cause dry skin in few cases only. However, the exact cause behind dry skin is unknown. If you are experiencing excessive dryness of skin after applying this drug then you are advised to use a skin moisturizer. Skin moisturizer should be applied only after 30 minutes of applying this drug so that the Clobetasol + Clotrimazole + Fusidic Acid can be absorbed by the skin.
Clobetasol + Clotrimazole + Fusidic Acid is a brand name of clobetasol and it comes in the form of ointment, cream, and lotion. It belongs to the class of drug known as steroids (corticosteroids). It is a prescription drug used for the treatment of skin diseases such as corticosteroid-responsive dermatoses, scalp psoriasis, and plaque psoriasis.
Application of Clobetasol + Clotrimazole + Fusidic Acid on the face must be avoided but if it has been advised by your doctor then you can use it only for a short-term period not more than 5 days because the skin on your face thins easily.
Yes, Clobetasol + Clotrimazole + Fusidic Acid might cause hair loss (alopecia). It is a rare side effect of this drug and the exact cause behind hair loss is unknown. For partial hair loss, you are advised to use hair solution such as minoxidil.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1313-1314
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 759
